Penny Stocks Icon

Penny Stocks

Penny stocks trade at less than $5 per share. They are highly volatile and incredibly risky investments that can burn new and seasoned investors alike; they often serve as the playground for scam artists and market manipulators. However, while penny stocks can be halved in the blink of an eye, they can also double much more quickly than large-cap stocks. Investors interested in penny stocks should be aware of the risks and do their due diligence before making an investment. Read on to find out how to profit without getting scammed.

Recent Penny Stocks Articles

Why Is Mullen (MULN) Stock Heating Up Today?

Investors appear to be pricing in a number of bullish catalyst into MULN stock today, but is that the right move in this environment?

5 Investors Betting Big on BuzzFeed (BZFD) Stock Right Now

BZFD stock is accelerating higher following the company's announcement that it will employ OpenAI's API to create content.

5 Investors Betting Big on Applied UV (AUVI) Stock Right Now

AUVI stock is flying higher following news that the company had hired a law firm to investigate naked short selling.

KERN Stock Alert: Akerna Plans to Merge With Gryphon Digital Mining

Akerna (KERN) stock is on the move Friday after the company revealed plans to merge with crypto company Gryphon Digital Mining.

Why Is Quince Therapeutics (NASDAQ:QNCX) Stock Up 53% Today?

Quince Therapeutics (QNCX) stock is rocketing higher on Friday after completing an asset sale to Lighthouse Pharmaceuticals.

AUVI Stock Alert: What to Know as Applied UV Takes on Naked Short Sellers

Applied UV (AUVI) stock is climbing higher on Friday after the company revealed plans to tackle alleged illegal short selling of its shares.

Why Is GeneDx (WGS) Stock Down 8% Today?

GeneDx (WGS) stock is taking a beating on Friday after the company revealed a $150 million proposed public stock offering.

Why Is ContraFect (CFRX) Stock Down 23% Today?

ContraFect (CFRX) stock is falling on Friday after the company provided an update on its potential delisting from the Nasdaq Capital Market.

Why Is Redhill Biopharma (RDHL) Stock Up 32% Today?

Redhill Biopharma (RDHL) stock is rocketing higher on Friday after getting positive patent news from the USPTO for RHB-204.

7 Penny Stocks Getting Ready for a Major Breakout

If you can handle the potentially extreme volatility of speculate ventures, these penny stocks may be on the move soon.

Why Is Akanda (NASDAQ:AKAN) Stock Up 200% Today?

Cannabis firm Akanda bounced dramatically higher due to an FDA announcement, but traders need to be careful with AKAN stock.

Why Is Cryptyde (TYDE) Stock Moving Today?

Cryptyde (TYDE) stock is on the move Thursday as investors react to the company's strong revenue guidance for the full year of 2023.

Why Is Inhibikase Therapeutics (IKT) Stock Down 11% Today?

Inhibikase Therapeutics (IKT) stock is falling on Thursday after the company announced a registered direct offering and private placement.

Why Is Ocuphire Pharma (OCUP) Stock Down 20% Today?

Ocuphire Pharma (OCUP) stock is falling on Thursday after the company posted mixed results from a Phase 2 clinical trial.

3 Penny Stocks to Buy Now OR You’ll Be Kicking Yourself Later

These are the penny stocks that look undervalued at current levels and can deliver multibagger returns in the coming years.

Helbiz (HLBZ) Stock Falls 20% as CEO Wages #NakedShortWar

Today, investors in Helbiz and HLBZ stock are in selling mode despite renewed calls for a war on naked short selling.

Short Squeeze Stocks: 5 Stocks Wall Street Really DOESN’T Want to Win

As potential short-squeeze stocks continue to capture the interest of retail traders, keep an eye on these stocks with high short interest.

Why Is Sonoma Pharmaceuticals (SNOA) Up 70% Today?

Sonoma Pharmaceuticals (SNOA) stock is rocketing higher on Wednesday following positive news for its Microcyn Rx products.

Why Is Grom Social Enterprises (GROM) Stock Down 30% Today?

Grom Social Enterprises (GROM) stock is falling on Wednesday after the company revealed details of a $3 million private placement.